PDFs Author/s Title / External Links

General

 

The Ocular Surface Journal
July 2017
Volume 15, Issue 3, p269-650

TFOS International Dry Eye WorkShop (DEWS II) 
  C Baudouin et al.  Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction
  The Ocular Surface Journal  
April 2007 
Volume 5, Number 2
International Dry Eye Workshop (DEWS) 2007  
  Pasquale Aragona, Vincenzo Papa, Antonio Micali, 
Marcello Santocono, Giovanni Milazzo  
Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye 
  H Mochizuki, M Yamada, 
S Hato and T Nishida  
Fluorophotometric measurement of the precorneal residence time of topically applied hyaluronic acid
  Brignole F, Pisella PJ, Dupas B, Baeyens V, Baudoin C 
Graefes Arch Clin Exp Ophthalmol. 2005 Jun;243(6):531-8. Epub 2004 Dec 17
Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis 
  Prabhasawat P, Tesavibul N, Kasetsuwan N. 
Br. J. Ophthalmol. 2007;91;47-50
Performance profile of sodium hyaluronate in patients with lipid tear deficiency: randomised, double-blind, controlled, exploratory study  

VISMED® 

  Ralph Pinheiro, Claudia Panfil, Norbert Schrage, Ralf Michael Dutescu

Comparison of the lubricant eyedrops Optive®, Vismed Multi®, and Cationorm® on the corneal healing process in an ex vivo model

  Roger Vogel, R. Stephens Crockett, Neal Oden, Terry W. Laliberte, and Luis Molina, on behalf of the sodium hyaluronate ophthalmic solution study group  Demonstration of Efficacy in the Treatment of Dry Eye Disease with 0.18% Sodium Hyaluronate Ophthalmic Solution (Vismed, Rejena)  
  C.A. Kirby, and The Vismed Study Group. Invest. Ophthalmol. Vis. Sci. 2009; 50 : E-Abstract 4648-D892. Poster presented at the ARVO, Fort-Lauderdale, 3-7 May 2009 Superiority of Vismed® (Sodium Hyaluronate Ophthalmic Solution 0.18%) Compared with its Vehicle in the Treatment of the Signs and Symptoms of Dry Eye Disease 
  Baeyens V, Fiorentini R, 
Baudouin C, Dorsey F and The French VISMED® Study Group 
Efficacy and safety of sodium hyaluronate 0.18% (VISMED®) vs sodium chloride 0.9% in patients with bilateral moderate dry eye 
  Zeher M, Bereczki Á, Sohajda Z, Márta J, Deák G, Ibnou-Zekri N, Baeyens V, poster presented at the 7th International Symposium on Ocular Pharmacology (ISOPT)-Budapest, Hungary, February 28- March 2, 2008  A 1-month study of efficacy and safety of 0.18% sodium hyaluronate (Vismed®) vs. 0.3% carbomer and 0.9% saline in patients with bilateral moderate dry eye syndrome 
  Johnson ME, Murphy PJ, Boulton M 
Graefes Arch Clin Exp Ophthalmol. 2006 Jan;244(1):109-12. Epub 2005 Jun 28.
Effectiveness of sodium hyaluronate eyedrops in the treatment of dry eye 
  Aleo D, Bossy L, poster presented at the 7th International Symposium on Ocular Pharmacology (ISOPT)-Budapest, Hungary, February 28- March 2, 2008   Considerations on the risk of precipitation of calcium phosphate salts following the use of VISMED® (0.18% sodium hyaluronate) formulation 
  Rapisarda A, Battaglia F, Bossy L, poster presented at the 7th International Symposium on Ocular Pharmacology (ISOPT)-Budapest, Hungary, February 28- March 2, 2008  Efficacy and safety of hypotonic 0.18% sodium hyaluronate solution (VISMED®) in patients with moderate dry eye - A study of the osmolarity of the tear film  
  Michael E. Johnson 
Paul J. Murphy 
Mike Boulton  
Carbomer and Sodium Hyaluronate Eyedrops for Moderate Dry Eye Treatment  

VISMED® GEL 

  TRB Chemedica  VISMED® GEL (Non-Preserved Sodium Hyaluronate eye drops) for the Treatment of Symptoms of Ocular Dryness and Discomfort in Patients with Sjögren's Syndrome 
  Clive Peckar  The Use of Sodium Hyaluronate Gel 0.3% in the Management of Post-Keratoplasty Patients, Chronic Refractory Dry Eye Patients and other Surface Problems 
  Clive Peckar 
Article in Eurotimes.

Sodium Hyaluronate Based Products. Management of post-LASIK dry eye and other dry eye problems. 

 

Clive Peckar et al
Eurotimes Roundtable 

Current Trends in the management of dry eye

LASERVIS

  Dougherty P.J., Wellish K.L., Maloney R.K. (1994)  Excimer Laser Ablation Rate and Corneal Hydration. Am. J of Ophthalm. 118, 169-176 
  Arshinoff SA, Khoury E. 
J Cataract Refract Surg 1997; 23:1221-5.
HsS versus a balanced salt solution as a corneal wetting agent during routine cataract extraction and lens implantation  
  Alio J.L., Belda J.I., Shalaby A.: 
2001;108:1246-1260 American Academy of Ophthalmology 
Correction of Irregular Astigmatism with Excimer Laser Assisted by Sodium Hyaluronate  
  Vinciguerra P, Camesasca FI. 
J Refract Surg 2002; 18(3 Suppl):S371-3. 
Butterfly laser epithelial keratomileusis for myopia  
  Lombardo M, Serrao S.(2004): 
Excimer Lasers. Journal of Refractive Surgery Vol 20 September/October 2004 
Smoothing of the ablated porcine anterior corneal surface using Technolas Keratocor 217C and Nidek EC-5000 
  Vinciguerra P., Camesasca FI, Torres IM 
Journal of Refractive Surgery Volume 20 September/October (Suppl) 2004
One-year results of custom laser epithalial keratomileusis with the Nidek system  
  J Cataract Refract Surg 2005;31:39-47 ASCRS & ESCRS 
Vinciguerra P., Camesasca F.I., Torres Munoz M.I. (2005):  
Transition zone design and smoothing in custom laser-assisted subepithelial keratectomy  
  Vinciguerra P, Munoz MI, Camesasca FI, Grizzi F, Roberts C. 
J Cataract Refract Surg. 2005 Jan;31(1):82-7. 
Long-term follow-up of ultrathin corneas after surface retreatment with phototherapeutickeratectomy
  Lombardo M, De Santo MP, Barberi R, Serrao S. 
J Refract Surg. 2005 Sep-Oct;21(5):469-75 
Roughness of excimer laser ablated corneas with and without smoothing measured with atomic force microscopy   

VISIOL ®

  Belda JI, Artola A, Garcia-Manzanares MD, Ferrer C, Haroun HE, Hassanein A, Baeyens V, Munoz G, Aliò JL 
J Cataract Refract Surg 2005; 31:1213-1218 © 2005 ASCRS and ESCRS 
Hyaluronic acid combined with mannitol to improve protection against free-radical endothelial damage: Experimental Model 
  Miranda M, Bosch-Morell F, Belda JI, García-Manzanares MD, Barcia J, Alió JL, Romero FJ 
Ophthalmic Res. 2007;39(5):260-4. Epub 2007 Sep 12. 
Protective Effect of Viscoelastics against Retina Lipid Peroxidation 
  Peckar C, study results presented at the 24th congress of the Asia-Pacific Academy of Ophthalmology (APAO)-Bali, Indonesia, May 17th, 2009   New OVDs: Does 2% Sodium Hyaluronate (VISIOL®) have significant advantages over 1% Sodium Hyaluronate to justify its use in Routine Cataract Phacoemulsification? 

For other studies not shown on this list please contact TRB Chemedica (UK) Ltd:

TRB Chemedica (UK) Ltd
9 Evolution 
Lymedale Business Park 
Hooters Hall Road 
Newcastle-under-Lyme 
ST5 9QF

Tel: 0845 330 7556
Email: info@trbchemedica.co.uk